ArticleInternational journal of molecular medicine2025

Remimazolam alleviates myocardial ischemia/reperfusion injury and inflammation via inhibition of the NLRP3/IL‑1β pathway in mice.

Xueru Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.